Showing results (11-20 of 66) with videos related to
Sort By:
Pageof 7
Gene|September 12, 2012
Does cytochrome P450 1A1 MspI polymorphism increase acute lymphoblastic leukemia risk? Evidence from 2013 cases and 2903 controlsWenlei Zhuo, Liang Zhang, Zhiqun Qiu, et al.Journal of Experimental & Clinical Cancer Research : CR|August 1, 2012
CYP1A1 MspI polymorphism and acute myeloid leukemia risk: meta-analyses based on 5018 subjectsWenlei Zhuo, Liang Zhang, Yan Wang, et al.Experimental Biology and Medicine (Maywood, N.J.)|March 13, 2013
XRCC1 Arg399Gln polymorphism and bladder cancer risk: updated meta-analyses based on 5767 cases and 6919 controlsWenlei Zhuo, Liang Zhang, Lei Cai, et al.Biotechnology and Applied Biochemistry|September 8, 2007
Down-regulation of layilin, a novel hyaluronan receptor, via RNA interference, inhibits invasion and lymphatic metastasis of human lung A549 cellsZhengtang Chen, Wenlei Zhuo, Yan Wang, et al.Leukemia & Lymphoma|May 9, 2012
MDM2 SNP309 variation contributes to leukemia risk: meta-analyses based on 7259 subjectsWenlei Zhuo, Liang Zhang, Junjun Ling, et al.Plos One|July 31, 2012
Association of MDM2 SNP309 variation with lung cancer risk: evidence from 7196 cases and 8456 controlsWenlei Zhuo, Liang Zhang, Bo Zhu, et al.Plos One|October 12, 2012
Association between CYP1A1 Ile462Val variation and acute leukemia risk: meta-analyses including 2164 cases and 4160 controlsWenlei Zhuo, Liang Zhang, Bo Zhu, et al.American Journal of Translational Research|December 23, 2015
Fisetin, a dietary bioflavonoid, reverses acquired Cisplatin-resistance of lung adenocarcinoma cells through MAPK/Survivin/Caspase pathwayWenlei Zhuo, Liang Zhang, Yi Zhu, et al.International Journal of Oncology|May 24, 2017
miR‑181b‑5p mediates TGF‑β1-induced epithelial-to-mesenchymal transition in non-small cell lung cancer stem-like cells derived from lung adenocarcinoma A549 cellsXuetao Li, Jing Han, Haizhen Zhu, et al.Journal of Experimental & Clinical Cancer Research : CR|August 18, 2009
Polymorphisms of TP53 codon 72 with breast carcinoma risk: evidence from 12226 cases and 10782 controlsWenlei Zhuo, Yunsong Zhang, Zhaolan Xiang, et al.Pageof 7